Writing in the May 14, 2021 issue of The American Journal of Psychiatry, a multi-institution team of scientists led by researchers at University of California San Diego School of Medicine report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients. Medications commonly prescribed for schizophrenia linked to cognitive impairment
Aucun commentaire:
Enregistrer un commentaire